Martindale The Complete Drug Reference-39th
Martindale The Complete Drug Reference-40th
The world’s most comprehensive reference source about drugs and medicines
The new edition of Martindale: The Complete Drug Reference, provides you with practical, evidence-based, global guidance, allowing you to quickly understand the characteristics of drugs and their clinical uses.
Over 120 new monographs include:
• New antibacterials, such as delafloxacin, eravacycline, omadacycline, ozenoxacin, and plazomicin
• Further antivirals, including drugs active against HIV (bictegravir, dapivirine, doravirine, ibalizumab), smallpox (tecovirimat), cytomegalovirus (letermovir), influenza (baloxavir marboxil), and hepatitis C (glecaprevir, pibrentasvir, voxilaprevir)
• New treatment options for migraine (erenumab, fremanezumab, galcanezumab), narcolepsy (solriamfetol), hyperkalaemia (sodium zirconium cyclosilicate), postpartum depression (brexanolone), eosinophilic asthma (benralizumab), hypoactive sexual desire disorder (bremelanotide), glaucoma (netarsudil), African trypanosomiasis (fexinidazole), and irritable bowel syndrome (tenapanor)
• New antidiabetic drugs, including ertugliflozin, evogliptin, semaglutide, and sotagliflozin
• Further antineoplastics for treating cancers including PARP inhibitors (niraparib, rucaparib, talazoparib), PI3K inhibitors (alpelisib, copanlisib, duvelisib), and CAR-T therapies (axicabtagene ciloleucel, tisagenlecleucel)
• Novel targeted treatments for retinal dystrophy (voretigene neparvovec), neurotrophic keratitis (cenegermin), paroxysmal nocturnal haemoglobinuria (ravulizumab), hereditary transthyretin amyloidosis (inotersen, patisiran), spinal muscular atrophy (nusinersen), and hereditary angioedema (lanadelumab)
Updated coverage of proprietary preparations in 43 countries including Australia, China, UK, and USA
Martindale: The Complete Drug Reference is a one-stop authoritative, invaluable reference work covering all aspects of drugs and medicines, essential on any bookshelf. It provides you with:
• Over 6,400 drug monographs summarising the nomenclature, properties, and actions of each substance – all in one book, giving you quick and easy access
• Over 125,000 preparations from 43 countries and regions
• Nearly 700 treatment reviews, with references from the published literature
• 5,600 + pharmaceutical terms and routes of administration in 13 major European languages
• Over 60,000 reference citations and over 25,000 international manufacturers and distributors
• Herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, poisons
Analytical Chemistry in GMP enviroment: A Practical Guide, John Wiley, James M. Miller, Jonathan B Crowther, USA, 1st, QFB
Official Methods of Analysis
ASHP’s New and Expanded Guide to IV Compatibility & Stability
For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug InformationTM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.
ASHP® Injectable Drug InformationTM 2021 now comes complete with 2 years of digital interactive access and a print edition to ensure you have constant, uninterrupted access. The digital content is interactive, mobile, and updated quarterly. Your 2 years of digital interactive access also includes linked monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information. Current 2021 edition features 18 new monographs and nearly 200 new references for a total of over 24,000 total compatibility pairs.
Official Methods of Analysis 2023
ASHP’s New and Expanded Guide to IV Compatibility & Stability
For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug InformationTM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.
ASHP® Injectable Drug InformationTM 2023 now comes complete with 2 years of digital interactive access and a print edition to ensure you have constant, uninterrupted access. The digital content is interactive, mobile, and updated quarterly. Your 2 years of digital interactive access also includes linked monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information. Current 2023 edition features 18 new monographs and nearly 200 new references for a total of over 24,000 total compatibility pairs.
Oral Lipd-Based Formulations
Enhancing the Bioavailablility of Poorly Water-Soluble Drugs
Process Chemistry in the Pharmaceutical Industry: Volume 2
Sterile Dosage Forms
